Teva Pharma acquires Japanese drug manufacturer Taiyo
With this acquisition, Teva will own around 550 products of Taiyo including all its local regulatory expertise and production facility in Japan. The acquisition also allows Teva to
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.